Want to join the conversation?
Phil Gibbs of KeyBanc Capital Markets asks about the structural business. EVP Chad Utermark said that as $NUE enters into 3Q16, demand in structural business is relatively flat with a decent backlog. He added that the structural business is pretty steady.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?